NNVC

NanoViricides, Inc

$1.30

0.20 (13.33%) Today

— up— down

Market Cap

$33M-8.5%

Revenue (TTM)

$0

$0

Net Income (TTM)

$-11,125,200

$-11,125,200

EPS (TTM)

-0.44

-0.44

Shares Out

25.40M

25.40M

Open

$1.30

$1.30

Previous Close

$1.50

$1.50

Day Range

$1.28 – $1.56

$1.28 – $1.56

52-Week Range

$0.85 – $2.23

$0.85 – $2.23

Beta

1.90

1.90

Volume

955.34K

955.34K

Avg Volume

792.67K

792.67K

Analyst Rating

Buy

Buy

Exchange

NYSE MKT LLC

NYSE MKT LLC

About NNVC

Related

News

NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Is In Phase II Clinical Trials

Yahoo · 17h ago

Nanoviricides Q4 EPS $(0.10), Inline

Benzinga · 1d ago

Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides

Yahoo · 1d ago

Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides

Yahoo · 6d ago